L. Van den Bosch

849 total citations
24 papers, 520 citations indexed

About

L. Van den Bosch is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, L. Van den Bosch has authored 24 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Otorhinolaryngology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Radiation. Recurrent topics in L. Van den Bosch's work include Head and Neck Cancer Studies (16 papers), Advanced Radiotherapy Techniques (7 papers) and Oral health in cancer treatment (4 papers). L. Van den Bosch is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Advanced Radiotherapy Techniques (7 papers) and Oral health in cancer treatment (4 papers). L. Van den Bosch collaborates with scholars based in Netherlands, Belgium and China. L. Van den Bosch's co-authors include Johannes A. Langendijk, Hans Paul van der Laan, R.J.H.M. Steenbakkers, Roel J.H.M. Steenbakkers, A. van der Schaaf, Johanna G.M. van den Hoek, Stefan Both, Charlotte L. Brouwer, Lisanne V. van Dijk and Mark J. Gooding and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Radiotherapy and Oncology.

In The Last Decade

L. Van den Bosch

19 papers receiving 519 citations

Peers

Countries citing papers authored by L. Van den Bosch

Since Specialization

Citations

This map shows the geographic impact of L. Van den Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Van den Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Van den Bosch more than expected).

Fields of papers citing papers by L. Van den Bosch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Van den Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Van den Bosch. The network helps show where L. Van den Bosch may publish in the future.

Co-authorship network of co-authors of L. Van den Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of L. Van den Bosch. A scholar is included among the top collaborators of L. Van den Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Van den Bosch. L. Van den Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort 2025 ·Oral Oncology ·(unknown), (unknown), L. Van den Bosch, (unknown), (unknown), Hung Chu, Yan Li, (unknown), Hans Paul van der Laan, Jolien Heukelom, Peter van Luijk, A. van der Schaaf, R.J.H.M. Steenbakkers, Nanna M. Sijtsema, Katherine A. Hutcheson, Clifton D. Fuller, Johannes A. Langendijk, Amy C. Moreno, Lisanne V. van Dijk	2
2	An efficient strategy to select head and neck cancer patients for adaptive radiotherapy 2023 ·Radiotherapy and Oncology ·(unknown), Johannes A. Langendijk, A. van der Schaaf, L. Van den Bosch, (unknown), Zhixiong Lin, Stefan Both, Charlotte L. Brouwer	11
3	Validation of the 18F-FDG PET image biomarker model predicting late xerostomia after head and neck cancer radiotherapy 2023 ·Radiotherapy and Oncology ·Yan Li, Nanna M. Sijtsema, (unknown), R.J.H.M. Steenbakkers, Fan Zhang, Walter Noordzij, L. Van den Bosch, Johannes A. Langendijk, Lisanne V. van Dijk	6
4	The relation between prediction model performance measures and patient selection outcomes for proton therapy in head and neck cancer 2022 ·Radiotherapy and Oncology ·Artuur Leeuwenberg, Johannes B. Reitsma, L. Van den Bosch, Jeroen Hoogland, A. van der Schaaf, Frank Hoebers, Oda B. Wijers, Johannes A. Langendijk, Karel G.M. Moons, Ewoud Schuit	2
5	Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients 2022 ·Radiotherapy and Oncology ·(unknown), (unknown), L. Van den Bosch, Johanna G.M. van den Hoek, (unknown), Tineke W.H. Meijer, György B. Halmos, Max J. H. Witjes, Sjoukje F. Oosting, Anouk van der Hoorn, Johannes A. Langendijk, R.J.H.M. Steenbakkers	24
6	Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment 2021 ·Radiotherapy and Oncology ·L. Van den Bosch, A. van der Schaaf, Hans Paul van der Laan, Frank Hoebers, Oda B. Wijers, Johanna G.M. van den Hoek, Karel G.M. Moons, Johannes B. Reitsma, R.J.H.M. Steenbakkers, Ewoud Schuit, Johannes A. Langendijk	76
7	Quality of life and toxicity guided treatment plan optimisation for head and neck cancer 2021 ·Radiotherapy and Oncology ·Hans Paul van der Laan, A. van der Schaaf, L. Van den Bosch, Erik W. Korevaar, R.J.H.M. Steenbakkers, Stefan Both, Johannes A. Langendijk	12
8	Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer 2021 ·Radiotherapy and Oncology ·Hans Paul van der Laan, L. Van den Bosch, Ewoud Schuit, Roel J.H.M. Steenbakkers, A. van der Schaaf, Johannes A. Langendijk	37
9	Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation 2021 ·International Journal of Radiation OncologyBiologyPhysics ·L. Van den Bosch, Hans Paul van der Laan, A. van der Schaaf, Sjoukje F. Oosting, György B. Halmos, Max J. H. Witjes, (unknown), Tineke W.H. Meijer, Johanna G.M. van den Hoek, Roel J.H.M. Steenbakkers, Johannes A. Langendijk	30
10	OC-0517 Importance of dose to the parotid gland stem cell rich region in preventing xerostomia in RT for HNC 2021 ·Radiotherapy and Oncology ·(unknown), Peter van Luijk, L. Van den Bosch, (unknown), (unknown), Tineke W.H. Meijer, Johannes A. Langendijk, (unknown)	0
11	Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose 2021 ·Radiotherapy and Oncology ·(unknown), Hans Paul van der Laan, Hendrik P. Bijl, L. Van den Bosch, Johanna G.M. van den Hoek, (unknown), Roel J.H.M. Steenbakkers, Johannes A. Langendijk	23
12	PD-0775 External validation of photon-derived NTCP models for acute toxicity in head and neck proton therapy 2021 ·Radiotherapy and Oncology ·L. Van den Bosch, A. van der Schaaf, Hans Paul van der Laan, (unknown), Tineke W.H. Meijer, (unknown), (unknown), Johannes A. Langendijk	0
13	Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy 2020 ·Radiotherapy and Oncology ·L. Van den Bosch, Ewoud Schuit, Hans Paul van der Laan, Johannes B. Reitsma, Karel G.M. Moons, Roel J.H.M. Steenbakkers, Frank Hoebers, Johannes A. Langendijk, A. van der Schaaf	34
14	Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy 2020 ·Radiotherapy and Oncology ·(unknown), L. Van den Bosch, Johanna G.M. van den Hoek, Hendrik P. Bijl, (unknown), Anouk van der Hoorn, Sjoukje F. Oosting, György B. Halmos, Max J. H. Witjes, Hans Paul van der Laan, Johannes A. Langendijk, Roel J.H.M. Steenbakkers	97
15	Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring 2019 ·Radiotherapy and Oncology ·Lisanne V. van Dijk, L. Van den Bosch, Paul Aljabar, Devis Peressutti, Stefan Both, R.J.H.M. Steenbakkers, Johannes A. Langendijk, Mark J. Gooding, Charlotte L. Brouwer	153
16	EP-1914 A method to deal with highly correlated explanatory variables in the development of NTCP models 2019 ·Radiotherapy and Oncology ·A. van der Schaaf, L. Van den Bosch, (unknown), Ewoud Schuit, Johannes A. Langendijk	1
17	Quality of Life Based Total Cost Function (TCF) to Guide Treatment Plan Optimization for Head and Neck Cancer 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Hans Paul van der Laan, L. Van den Bosch, A. van der Schaaf, (unknown), (unknown), (unknown), A. Hoek, Stefan Both, (unknown), Johannes A. Langendijk	1
18	WGS implementation in standard cancer diagnostics for every cancer patient (WIDE) 2019 ·Annals of Oncology ·Paul Roepman, L. Van den Bosch, Kris G. Samsom, Luuk J. Schipper, Ewart de Bruijn, Louisa R. Hoes, (unknown), (unknown), Lizet van der Kolk, (unknown), Emile E. Voest, Edwin Cuppen, Kim Monkhorst, Gerrit A. Meijer	3
19	OC-0393 Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with RT 2019 ·Radiotherapy and Oncology ·(unknown), L. Van den Bosch, A. Hoek, (unknown), (unknown), Elisabeth Van Aken, Hans Paul van der Laan, Johannes A. Langendijk, R.J.H.M. Steenbakkers	2
20	OC-0418: Quantitative evaluation of deep learning contouring of head and neck organs at risk 2018 ·Radiotherapy and Oncology ·Henri M. de Bakker, Devis Peressutti, (unknown), Lisanne V. van Dijk, L. Van den Bosch, Mark J. Gooding, Charlotte L. Brouwer	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact